Moving Toward Better Health: Managing Type 2 Diabetes Through Lifestyle, Exercise, and Awareness

Type 2 diabetes is a chronic condition that affects how the body processes blood sugar (glucose). With over 37 million people in the U.S. living with diabetes (Centers for Disease Control and Prevention [CDC], 2022), and many more with prediabetes or undiagnosed insulin resistance, understanding how to manage blood glucose is more critical than ever.

While medication is often necessary for glucose control, it’s not the only tool in the toolbox. A lifestyle rooted in movement, mindful eating, and consistent monitoring can significantly reduce blood sugar spikes and complications (American Diabetes Association [ADA], 2023). This article explores how blood sugar behaves in the body, what causes it to spike, and how you can intervene through everyday habits.

The Broader Picture of Diabetes Management

In addition to well-known fluctuations like post-meal spikes and early morning hyperglycemia, several lesser known but equally important complications contribute to the broader health burden of type 2 diabetes. These include chronic hyperglycemia, which silently damages blood vessels and organs over time, as well as acute hypoglycemia, which poses immediate risks. Inflammatory conditions such as gum disease also show a strong correlation with diabetes, creating a two-way relationship that can worsen metabolic control.

Understanding these additional concerns enhances the ability to prevent complications and supports a more comprehensive approach to diabetes care.

The Danger of Low Blood Sugar: Hypoglycemia

While high blood sugar gets the most attention, hypoglycemia, when blood sugar drops too low is also dangerous. Hypoglycemia is typically defined as blood glucose below 70 mg/dL (ADA, 2023) and can cause symptoms such as shakiness, sweating, confusion, irritability, and even loss of consciousness.

The Dangers of High Blood Sugar: Hyperglycemia

Chronic hyperglycemia, or persistently elevated blood glucose levels, is a hallmark of type 2 diabetes and a major contributor to its long-term complications. Over time, excess glucose circulating in the bloodstream leads to damage in both small and large blood vessels. This damage is systemic, affecting the eyes, kidneys, nerves, brain, and cardiovascular system. Unlike the immediate symptoms of hypoglycemia, the consequences of high blood sugar often develop silently, making consistent glucose monitoring and control essential even in the absence of symptoms.

• Cardiovascular disease: High blood sugar contributes to the formation of plaques in the arteries, known as atherosclerosis, increasing the risk of heart attacks and strokes. People with diabetes are nearly twice as likely to die from heart disease or stroke than those without it.

• Kidney disease: Excess glucose can damage the delicate filtration system in the kidneys, eventually leading to chronic kidney disease or end-stage renal failure.

• Retinopathy and vision loss: The blood vessels in the eyes are highly sensitive to elevated glucose. Without management, this can lead to diabetic retinopathy, blurred vision, or even blindness.

• Neuropathy: Nerve damage from prolonged hyperglycemia can cause tingling, pain, or numbness, most commonly in the feet and increases the risk of infections and amputations.

• Cognitive decline and dementia: Research shows that people with type 2 diabetes have a 60% higher risk of developing dementia (Biessels et al., 2020). Glucose toxicity, insulin resistance in the brain, and microvascular damage all contribute to neurodegeneration, increasing susceptibility to both vascular dementia and Alzheimer’s disease.

  
  

Diabetes and Gum Disease: Which Comes First?

The relationship between diabetes and gum disease (periodontitis) is bidirectional, meaning one can exacerbate the other. Persistent high blood glucose levels impair blood flow, weaken immune responses, and increase the risk of infection, making it easier for bacteria to inflame the gums. On the other hand, chronic inflammation caused by untreated gum disease can increase insulin resistance and make it more difficult to manage blood sugar levels.

• People with diabetes are 2–3 times more likely to develop gum disease (Mealey & Oates, 2006), and severity often correlates with poor glycemic control.

• Inflammation in the gums leads to increased production of cytokines and inflammatory markers, which can enter the bloodstream and contribute to systemic insulin resistance.

• Conversely, improving oral hygiene and receiving periodontal treatment has been shown to reduce A1c levels slightly, offering both dental and metabolic benefits.

  
  

Given this connection, dental care should be a routine part of diabetes management. Furthermore, chronic gum disease has been independently linked to an increased risk of cardiovascular disease, including heart attacks and stroke. The inflammation associated with periodontal disease may contribute to systemic atherosclerosis and endothelial dysfunction, compounding the already elevated cardiovascular risk faced by individuals with diabetes (Mealey & Oates, 2006).

Regular cleanings, daily flossing, and blood sugar control together help break the cycle of inflammation and insulin resistance.

Current Treatment Options: Supporting the Body with Science

The management of type 2 diabetes has evolved significantly, with a growing array of medications that target different mechanisms involved in glucose regulation. These pharmacologic agents are not just about lowering blood sugar, they also help reduce the risk of complications like cardiovascular disease and kidney failure, making them essential tools in comprehensive diabetes care.

• Metformin: Often the first-line treatment, it reduces hepatic glucose production, improves peripheral insulin sensitivity, and modestly aids in weight stabilization (Nathan et al., 2009). It's effective, low-cost, and well-tolerated by most patients.

• SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin): These help the kidneys eliminate excess glucose through urine. In addition to improving glycemic control, they offer cardiovascular and renal protection and can aid in modest weight loss (Zinman et al., 2015).

• GLP-1 receptor agonists (e.g., semaglutide, liraglutide): These drugs mimic the action of the glucagon-like peptide-1 hormone. They enhance insulin secretion in response to meals, slow gastric emptying, reduce appetite, and promote weight loss. Studies show they also reduce cardiovascular events in patients with diabetes and preexisting heart disease (Marso et al., 2016).

• DPP-4 inhibitors (e.g., sitagliptin, linagliptin): These increase the body's own incretin hormones, which help control blood sugar after meals. They are generally weight-neutral and have a low risk of hypoglycemia.

• Insulin therapy: Essential when beta-cell function declines or when oral medications are insufficient. Insulin can be used in basal or mealtime dosing strategies and is often introduced in more advanced stages of the disease or during acute illness.

  
  

What Happens After Diagnosis? Secondary Care and Monitoring

Diabetes management doesn't end with diagnosis, it marks the beginning of a lifelong process of monitoring and risk reduction. The goal of secondary care is to prevent or delay the onset of complications through regular assessment, patient education, and lifestyle or medication adjustments.

• Regular A1c testing (every 3–6 months) (ADA, 2023): Helps monitor long-term glycemic control and adjust treatments accordingly.

• Blood pressure and lipid profile monitoring: Since individuals with diabetes are at higher risk for cardiovascular disease, controlling hypertension and dyslipidemia is critical.

• Annual foot exams: Detect early signs of neuropathy, ulcers, and circulation issues that can lead to infection or amputation if left unaddressed.

• Kidney function screening: Tests like urine albumin-to-creatinine ratio and estimated glomerular filtration rate (eGFR) help catch diabetic nephropathy early.

• Retinal exams: Annual eye exams can detect diabetic retinopathy and prevent vision loss through early treatment.

• Vaccinations: People with diabetes are at greater risk of infections, so staying up-to-date with influenza, pneumococcal, hepatitis B, and COVID-19 vaccines is important.

• Behavioral health and nutrition counseling: Support from diabetes educators, dietitians, and behavioral health providers helps reinforce sustainable self-management strategies.

Routine and coordinated follow-up ensures that even silent complications are addressed early, helping patients live healthier, longer lives with diabetes.

The Case for Diabetes Remission

The concept of "diabetes remission" has gained growing acceptance in clinical medicine. Rather than focusing solely on managing symptoms with increasing medication, remission shifts the goal toward regaining glycemic control through targeted interventions, especially in the early stages of type 2 diabetes.

According to leading health organizations, type 2 diabetes is considered in remission when:

• HbA1c is below 6.5

• Fasting glucose remains below diabetic thresholds

• These levels are maintained for at least 3 to 6 months

• All without the use of glucose-lowering medications (Riddle et al., 2021)

Remission does not mean the disease is cured. Rather, it signals that the metabolic dysfunction has been effectively halted or significantly reduced. This milestone, if sustained, can improve quality of life, reduce medication dependence, and dramatically lower the risk of long-term complications such as cardiovascular disease, kidney failure, and nerve damage.

How Is Remission Achieved?

Remission is most likely to occur in individuals who:

• Are diagnosed early, before significant beta-cell damage occurs

• Achieve and maintain significant weight loss, particularly visceral (abdominal) fat

• Follow a structured dietary intervention such as a low-calorie, low-carb, or Mediterranean-style plan

• Engage in regular physical activity (at least 150 minutes per week)

• Manage stress and prioritize sleep, both of which impact insulin sensitivity

Research from the DiRECT trial in the UK demonstrated that over 45% of participants who underwent an intensive weight-loss program achieved remission within one year and many maintained it after two years with continued lifestyle support.

Why It Matters

The pursuit of remission changes the conversation around type 2 diabetes from one of chronic deterioration to one of empowerment and potential recovery. With clinical supervision and sustained behavioral changes, many patients can experience a return to near-normal metabolic health.

"Remission is not the end of diabetes care—it's a new beginning that requires commitment but brings the reward of long-term wellness."

The Power of Movement

Exercise is one of the most powerful non-pharmacological tools for managing type 2 diabetes. Physical activity helps the body use insulin more efficiently and directly lowers blood glucose levels, making it especially effective for people with insulin resistance.

How It Works:

When muscles contract during physical activity, they stimulate the uptake of glucose from the bloodstream into muscle cells, even without insulin. This process helps reduce blood glucose levels almost immediately and can continue to improve insulin sensitivity for up to 24 to 48 hours after the workout (ADA, 2023).

• Aerobic exercise (e.g., brisk walking, swimming, cycling) improves cardiovascular health and lowers glucose levels.

• Resistance training (e.g., weightlifting, resistance bands) builds muscle mass, which increases resting metabolic rate and glucose utilization.

• Flexibility and balance exercises (e.g., yoga, tai chi) support joint health and reduce fall risk, especially important for older adults with diabetes.

Even light movement, such as walking after meals, can reduce postprandial blood glucose spikes and support better glycemic control throughout the day.

Fueling Your Body: Low vs. High Glycemic Foods

Food has a profound and immediate effect on blood sugar regulation. One of the most effective ways to support metabolic control is to understand and choose foods based on their glycemic index (GI), a measure of how quickly a food raises blood glucose levels.

Avoid High-Glycemic Foods:

High-GI foods break down quickly in the body, causing rapid spikes in blood glucose. Frequent consumption of these foods can lead to poor glycemic control, fatigue, and an increased risk of complications. Common high-GI foods include:

• White bread

• White rice

• Sugary cereals

• Baked goods made with refined flour

• Sweetened beverages and fruit juices

  
  

Embrace Low-Glycemic Foods:

Low-GI foods digest more slowly, resulting in a gradual release of glucose and a more stable blood sugar response. These foods also tend to be higher in fiber and nutrients:

• Whole grains like quinoa and steel-cut oats

• Legumes such as lentils and chickpeas

• Non-starchy vegetables including broccoli, kale, and okra

• Healthy fats from avocado, nuts, and olive oil

• Lean proteins like chicken, fish, tofu, and eggs

  
  

Food Pairing and Meal Composition:

It's not just what you eat, but how you combine foods and the order in which you eat them, that impacts blood glucose. Consuming fiber-rich vegetables and protein before carbohydrates has been shown to blunt the postprandial glucose rise and improve insulin response (Shukla et al., 2015).

Additionally, spacing out carbohydrates evenly throughout the day, avoiding large, carb-heavy meals, and choosing high-fiber, unprocessed options can make meals more blood sugar–friendly. Small changes in how meals are structured can lead to major improvements in glycemic stability and energy levels.

It's also beneficial to include healthy fats and protein with each meal and snack to slow gastric emptying and reduce the speed at which glucose enters the bloodstream. For example, pairing apple slices with almond butter or including avocado with whole-grain toast can promote better glucose regulation than carbohydrates alone.

Staying hydrated, avoiding highly processed snacks, and being mindful of added sugars in sauces, condiments, and beverages also support glycemic balance. For individuals with type 2 diabetes, creating balanced, satisfying meals that do not result in large glucose swings is critical not only for managing blood sugar but also for maintaining energy, reducing cravings, and preventing long-term complications.

Interested in learning more about clinical decision-making in geriatrics?

Explore evidence-based updates, real-world case discussions, and tools to sharpen your diagnostic approach to older adults. Click below to view the upcoming intensive learning opportunity.

Click Me

References

American Diabetes Association. (2023). Standards of medical care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S1–S291. https://doi.org/10.2337/dc23-S001

Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2020). Dementia and cognitive decline in type 2 diabetes and prediabetic stages: Towards targeted interventions. The Lancet Diabetes & Endocrinology, 8(3), 264–273. https://doi.org/10.1016/S2213-8587(19)30081-5

Centers for Disease Control and Prevention. (2022). National diabetes statistics report. https://www.cdc.gov/diabetes/data/statistics-report/index.html

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., ... & Buse, J. B. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 375(4), 311–322. https://doi.org/10.1056/NEJMoa1603827

Mealey, B. L., & Oates, T. W. (2006). Diabetes mellitus and periodontal diseases. Journal of Periodontology, 77(8), 1289–1303. https://doi.org/10.1902/jop.2006.050459

Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009). Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm. Diabetes Care, 32(1), 193–203. https://doi.org/10.2337/dc08-9025

Riddle, M. C., Cefalu, W. T., Evans, P. H., Gerstein, H. C., Nauck, M. A., & van Raalte, D. H. (2021). Consensus report: Definition and interpretation of remission in type 2 diabetes. Diabetes Care, 44(10), 2438–2444. https://doi.org/10.2337/dci21-0034

Shukla, A. P., Iliescu, R. G., Thomas, C. E., & Aronne, L. J. (2015). Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care, 38(7), e98–e99. https://doi.org/10.2337/dc15-0429

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., ... & EMPA-REG OUTCOME Investigators. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117–2128. https://doi.org/10.1056/NEJMoa1504720